Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT03258320
Eligibility Criteria:
Inclusion Criteria:
* 40 ≤ age ≤ 75 years with histologically proven PCa
* no severe major organ dysfunction
* WHO performance status of 0 or 1
* no prior cancer chemotherapy
* A Clinical Stage ≥ T2c (T2c, N0, M0) of prostate cancer but without diagnosed distant metastasis (according to the 2016 American Joint Committee on Cancer (AJCC) definition of TNM staging system, Staging Manual, Eighth Edition) as determined by a preoperative evaluation that included a pleural computed tomography (CT) scan.
Exclusion Criteria:
* age ≥ 76
* severe major organ dysfunction
* WHO performance status of \>1
* prior cancer chemotherapy
* Stage IV.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
75 Years
Study:
NCT03258320
Study Brief:
Protocol Section:
NCT03258320